FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657
To access this article, please choose from the options below
PII: S0145-2126(10)00206-7
doi:10.1016/j.leukres.2010.04.004
© 2010 Elsevier Ltd. All rights reserved.
